home / stock / labp / labp quote
Last: | $22.33 |
---|---|
Change Percent: | 1.03% |
Open: | $22.13 |
Close: | $22.33 |
High: | $22.375 |
Low: | $22.13 |
Volume: | 10,749 |
Last Trade Date Time: | 05/10/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.33 | $22.13 | $22.33 | $22.375 | $22.13 | 10,749 | 05-10-2024 |
$22.36 | $22.1782 | $22.36 | $22.48 | $22.13 | 5,058 | 05-09-2024 |
$22.205 | $22.1459 | $22.205 | $22.2078 | $22.1201 | 5,249 | 05-08-2024 |
$22.17 | $22.18 | $22.17 | $22.2855 | $22.1201 | 7,834 | 05-07-2024 |
$22.15 | $22.1 | $22.15 | $22.195 | $22.02 | 6,357 | 05-06-2024 |
$22.235 | $22.2912 | $22.235 | $22.43 | $22.185 | 3,863 | 05-03-2024 |
$22.25 | $22.12 | $22.25 | $22.3624 | $21.91 | 6,316 | 05-02-2024 |
$22.2931 | $22.46 | $22.2931 | $22.46 | $22.15 | 9,671 | 05-01-2024 |
$22.3 | $22.46 | $22.3 | $22.46 | $22.18 | 1,677 | 04-30-2024 |
$22.4799 | $22.36 | $22.4799 | $22.49 | $22.2 | 3,969 | 04-29-2024 |
$22.31 | $22.35 | $22.31 | $22.5501 | $22.31 | 14,876 | 04-26-2024 |
$22.49 | $22.84 | $22.49 | $22.84 | $22.21 | 3,928 | 04-25-2024 |
$22.18 | $22.19 | $22.18 | $22.49 | $22.07 | 9,082 | 04-24-2024 |
$22.1501 | $21.9 | $22.1501 | $22.151 | $21.9 | 9,225 | 04-23-2024 |
$21.96 | $21.84 | $21.96 | $22.095 | $21.61 | 13,185 | 04-22-2024 |
$21.82 | $21.7 | $21.82 | $21.82 | $21.6 | 14,687 | 04-19-2024 |
$21.75 | $21.55 | $21.75 | $21.75 | $21.55 | 20,783 | 04-18-2024 |
$21.67 | $21.46 | $21.67 | $21.72 | $21.46 | 15,314 | 04-17-2024 |
$21.52 | $21.5 | $21.52 | $21.56 | $21.43 | 19,143 | 04-16-2024 |
$21.57 | $21.51 | $21.57 | $21.57 | $21.43 | 18,713 | 04-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Landos Biopharma Inc. Company Name:
LABP Stock Symbol:
NASDAQ Market:
NEW YORK, May 11, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
2024-05-06 13:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Friday, AbbVie Inc (NYSE:ABBV) reported first-quarter adjusted EPS of $2.31, down 6.1% Y/Y, beating the consensus of $2.23. Net...